{"ticker": {"uuid": "c16d05c0-7950-490a-b83a-895e50b4f8af", "symbol": "2487", "name": "Cutia Therapeutics", "exchange": "HKG", "country": "HK", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Dose Escalation Completed for Rise Therapeutics' R-3750 and R-2487 Clinical Trials", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxQRkNOdFJGU0JBQzQ5Rk5kSlFkOHBCVmk2Z0pCWkVZeV9TX1ZJY3dheXJXaWtRQjFqbnpXNDl2ZkgyNVdNWW44ZlNpUnVFNlRmcEJfdi01Tk5GRzlSZDhVU0JfRDNERmpsU01lOVEtek45S3RrV0YyVEFTZkZSTDFLTk92ZFpwMmUyLXQ5WFFDbC1RTVRJQjlFOXNuV19tT1VXQUxYMmMzTGdQNEdDa2ZGMGNmZ1dJbTl1MFVGdFhKcGNhd0ZadVBPNmpmNEpHbHpwYlRZ?oc=5", "source_name": "PR Newswire", "published_at": "2025-01-06T08:00:00+00:00", "published_display": "06 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rise Therapeutics begins rheumatoid arthritis therapy trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMifkFVX3lxTFBKb0Zob0JvcE56VnlvWjZjVElZSXBHU1dWX3F0QVRXSjNkYkJrdlFpVlZIWXl3TUVjb3RyOWZueWplMi1aN1JlVEZyQWZQQ29tY1JSUnp3RFU0amZleWJrUHp4R3o2WHNLZ2tEdHlxN2xxdlRvYng5Q1I4Q0xLZw?oc=5", "source_name": "Clinical Trials Arena", "published_at": "2024-01-30T08:00:00+00:00", "published_display": "30 Jan 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dermatology-focused Cutia raises $65M in Hong Kong IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNZUpaMTQtc3NrNDZuOUIzbklNY3ZSMm43Qm5FaXhHcXdoTVhCYTlVYm5lN0UtSHJFY3RsQkRsbm45dHVzU05BM1QzRGNrYmI0cVpmaXZZYW5ERWZNM3dYdFFoelVOdUFtVDlYc2tRN0dtaG10a1dyZGdPQ3BiN2Rta0U2VWlSMjNRZUN0NkpPYzA0ZU8tLVUwbDhn?oc=5", "source_name": "BioWorld News", "published_at": "2023-06-13T07:00:00+00:00", "published_display": "13 Jun 2023 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Dose Escalation Completed for Rise Therapeutics' R-3750 and R-2487 Clinical Trials", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxQRkNOdFJGU0JBQzQ5Rk5kSlFkOHBCVmk2Z0pCWkVZeV9TX1ZJY3dheXJXaWtRQjFqbnpXNDl2ZkgyNVdNWW44ZlNpUnVFNlRmcEJfdi01Tk5GRzlSZDhVU0JfRDNERmpsU01lOVEtek45S3RrV0YyVEFTZkZSTDFLTk92ZFpwMmUyLXQ5WFFDbC1RTVRJQjlFOXNuV19tT1VXQUxYMmMzTGdQNEdDa2ZGMGNmZ1dJbTl1MFVGdFhKcGNhd0ZadVBPNmpmNEpHbHpwYlRZ?oc=5", "source_name": "PR Newswire", "published_at": "2025-01-06T08:00:00+00:00", "published_display": "06 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rise Therapeutics begins rheumatoid arthritis therapy trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMifkFVX3lxTFBKb0Zob0JvcE56VnlvWjZjVElZSXBHU1dWX3F0QVRXSjNkYkJrdlFpVlZIWXl3TUVjb3RyOWZueWplMi1aN1JlVEZyQWZQQ29tY1JSUnp3RFU0amZleWJrUHp4R3o2WHNLZ2tEdHlxN2xxdlRvYng5Q1I4Q0xLZw?oc=5", "source_name": "Clinical Trials Arena", "published_at": "2024-01-30T08:00:00+00:00", "published_display": "30 Jan 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dermatology-focused Cutia raises $65M in Hong Kong IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNZUpaMTQtc3NrNDZuOUIzbklNY3ZSMm43Qm5FaXhHcXdoTVhCYTlVYm5lN0UtSHJFY3RsQkRsbm45dHVzU05BM1QzRGNrYmI0cVpmaXZZYW5ERWZNM3dYdFFoelVOdUFtVDlYc2tRN0dtaG10a1dyZGdPQ3BiN2Rta0U2VWlSMjNRZUN0NkpPYzA0ZU8tLVUwbDhn?oc=5", "source_name": "BioWorld News", "published_at": "2023-06-13T07:00:00+00:00", "published_display": "13 Jun 2023 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 80, "total_relevant": 3, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 2, "score": 55, "total": 3, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 1.65, "count": 3}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 2.65, "latest_week": "2026-07-10", "one_week_move": -3.3, "four_week_move": -17.7, "twelve_week_move": -44.2, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.445959, "market_dynamics_buy_signal": false, "relative_strength": -53.731641, "fair_value_gap": -71.0, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 39.9161, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-3.3% over one week, -17.7% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 63, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "PR Newswire", "count": 1}, {"label": "Clinical Trials Arena", "count": 1}, {"label": "BioWorld News", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 3}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 3}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "3", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-3.3% over one week, -17.7% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Dose Escalation Completed for Rise Therapeutics' R-3750 and R-2487 Clinical Trials"}], "updated_at": "2026-07-18T05:53:39.218133+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}